Pfizer denied that it was looking for a large acquisition. And I think they mean it. They want to buy rights and licenses for marketing drugs, since they are present in global markets with great distribution capabilities. That's their strategy. They will not shift away from that. They don't consider themselves as desperate so I really don't think they'll make a large acquisition.
They have only 3 year to limit the loss of Lipitor and their focus is on cutting costs and find great compounds and drugs. A big acquisition would be a relief for shareholders in the short run... but it would also mean that the company would lose focus. It is difficult to merge different business cultures in such a short period of time.
-
Pfizer denied that it was looking for a large acquisition. And I think they mean it. They want to buy rights and licenses for marketing drugs, since they are present in global markets with great distribution capabilities. That's their strategy. They will not shift away from that. They don't consider themselves as desperate so I really don't think they'll make a large acquisition.
Sep 09 06:58 am
|Rating:
0
0
All Comments by Ax »A Bayer Buyout by Pfizer? [View article]
They have only 3 year to limit the loss of Lipitor and their focus is on cutting costs and find great compounds and drugs. A big acquisition would be a relief for shareholders in the short run... but it would also mean that the company would lose focus. It is difficult to merge different business cultures in such a short period of time.
But if they do it, they should buy Biogen Idec.